LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Geschlossen

3.39 3.67

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.22

Max

3.44

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.5M -4.5M
Gewinnspanne	-2,954
Angestellte	21

Dividenden
By Dow Jones
Nächstes Ergebnis	6. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	3.3M 27M
Vorheriger Eröffnungskurs	-0.28
Vorheriger Schlusskurs	3.39

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Juni 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce to Buy m3ter in Nod Toward AI-Native Business Models

8. Juni 2026, 15:41 UTC

Wichtige Markttreiber

American Battery Shares Jump on Energy Department Victory

8. Juni 2026, 23:46 UTC

Market Talk

Nikkei May Rebound After Monday's Selloff -- Market Talk

8. Juni 2026, 23:37 UTC

Market Talk

Oil Edges Higher Amid Ongoing Supply Disruption Concerns -- Market Talk

8. Juni 2026, 23:25 UTC

Market Talk

Should Australia Consider State-Linked Commodities Export Desk? -- Market Talk

8. Juni 2026, 23:25 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Juni 2026, 21:57 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce Expects to Close Deal in 2Q of Fiscal 2027

8. Juni 2026, 21:56 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce Agrees to Buy m3ter

8. Juni 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

8. Juni 2026, 19:22 UTC

Market Talk

Oil Settles Higher as Israel-Iran Exchanges Raise Tension -- Market Talk

8. Juni 2026, 19:01 UTC

Market Talk

U.S. Natural Gas Futures Pull Back on Weather Outlook -- Market Talk

8. Juni 2026, 18:52 UTC

Market Talk

Global Energy Roundup: Market Talk

8. Juni 2026, 18:52 UTC

Market Talk

CAD Needs Trade Deal to Trigger Sustained Rally -- Market Talk

8. Juni 2026, 18:17 UTC

Market Talk

Oil Pulls Back Further As Iran, Israel Put Strikes on Hold -- Market Talk

8. Juni 2026, 17:32 UTC

Market Talk

Bank of Canada Should Incorporate Unemployment Rate Into Its Forecast -- Market Talk

8. Juni 2026, 17:29 UTC

Market Talk

Crypto Market Still Stays in 'Extreme Fear' Amid Rebound -- Market Talk

8. Juni 2026, 17:29 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Juni 2026, 16:55 UTC

Akquisitionen, Fusionen, Übernahmen

Monte dei Paschi: Mediobanca Integration Proceeding According to Plan

8. Juni 2026, 16:54 UTC

Akquisitionen, Fusionen, Übernahmen

Monte dei Paschi to Review Proposals From Banco BPM, Intesa Sanpaolo

8. Juni 2026, 16:40 UTC

Market Talk

Cryptocurrencies Rise After Iran and Israel Halt Exchanges of Fire -- Market Talk

8. Juni 2026, 16:31 UTC

Market Talk

No Recession in Canada, Scotiabank's CEO Says -- Market Talk

8. Juni 2026, 16:27 UTC

Market Talk

Mexican Inflation Seen Easing in May -- Market Talk

8. Juni 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. Juni 2026, 16:03 UTC

Akquisitionen, Fusionen, Übernahmen

Orange Bought Stake From Lorca

8. Juni 2026, 16:01 UTC

Akquisitionen, Fusionen, Übernahmen

Orange Completes Acquisition of Remaining 50% Stake in MasOrange

8. Juni 2026, 16:01 UTC

Akquisitionen, Fusionen, Übernahmen

Orange Acquires 100% Ownership of MasOrange

8. Juni 2026, 15:58 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Juni 2026, 15:58 UTC

Market Talk

Gold Trims Losses After Israel, Iran Halt Exchanges of Fire -- Market Talk

8. Juni 2026, 15:55 UTC

Market Talk

Markets Price Small Chance USMCA Will Be Dismantled -- Market Talk

8. Juni 2026, 15:41 UTC

Market Talk

Gold Falls Below 200-Day Moving Average -- Market Talk

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.